e-therapeutics (ETX) Stock Chart & Stock Price History → The only AI company you should be looking at (From Behind the Markets) (Ad) Free ETX Stock Alerts GBX 12.88 +0.48 (+3.83%) (As of 03/18/2024 09:28 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades e-therapeutics Stock Price Performance5 Day Performance+9.57%1 Month Performance-21.85%3 Month Performance+48.67%6 Month Performance-7.71%Year-To-Date Performance+56.25%1 Year Performance-11.21% Receive ETX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. ETX Stock Chart for Tuesday, March, 19, 2024 ETX Chart by TradingView e-therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/18/2024GBX 12.30GBX 12.90+4.88%GBX 12.90GBX 11.55468,220 shs£75.38 million03/15/2024GBX 11.75GBX 12.40+5.53%GBX 12.40GBX 11.66172,495 shs£72.46 million03/14/2024GBX 12.80GBX 11.75-8.20%GBX 12.95GBX 11.75160,861 shs£68.66 million03/13/2024GBX 12.58GBX 12.80+1.79%GBX 13.11GBX 12.35387,472 shs£74.79 million03/12/2024GBX 12.68GBX 12.58-0.79%GBX 12.58GBX 12.5734,703 shs£73.48 million03/11/2024GBX 13.13GBX 12.68-3.43%GBX 13GBX 12.6818,000 shs£74.06 million Get the Latest News and Ratings for ETX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/08/2024GBX 12.15GBX 13.13+8.02%GBX 13.50GBX 12.50139,759 shs£76.69 million03/07/2024GBX 12.53GBX 12.15-2.99%GBX 12.75GBX 12.15175,823 shs£71.00 million03/06/2024GBX 12.88GBX 12.53-2.72%GBX 12.95GBX 12.16173,627 shs£73.19 million03/05/2024GBX 12.65GBX 12.88+1.78%GBX 12.88GBX 12.6519,252 shs£75.23 million03/04/2024GBX 13.48GBX 12.65-6.12%GBX 13.24GBX 12.65188,471 shs£73.92 million03/01/2024GBX 13.73GBX 13.24-3.54%GBX 13.76GBX 13269,178 shs£77.36 million02/29/2024GBX 13.20GBX 13.73+3.98%GBX 14.30GBX 13959,545 shs£80.20 million02/28/2024GBX 14GBX 13.20-5.71%GBX 14GBX 13.20635,663 shs£77.13 million02/27/2024GBX 15GBX 14-6.67%GBX 14.78GBX 13.61338,848 shs£81.81 million02/26/2024GBX 16.13GBX 15-6.98%GBX 15.50GBX 15242,733 shs£87.65 million02/23/2024GBX 15.70GBX 16.13+2.71%GBX 16.13GBX 15.7529,030 shs£94.22 million02/22/2024GBX 16.35GBX 15.70-3.98%GBX 16.28GBX 15.70416,080 shs£91.74 million02/21/2024GBX 16.55GBX 16.35-1.21%GBX 16.55GBX 16.1145,308 shs£95.54 million02/20/2024GBX 16.48GBX 16.55+0.46%GBX 16.95GBX 16.10140,218 shs£96.71 million02/19/2024GBX 15.53GBX 16.48+6.12%GBX 16.50GBX 15.15474,969 shs£96.27 million02/16/2024GBX 15.60GBX 15.53-0.48%GBX 15.85GBX 15.0779,327 shs£90.72 million02/15/2024GBX 15.40GBX 15.60+1.30%GBX 15.88GBX 15.17288,127 shs£91.16 million02/14/2024GBX 15.25GBX 15.40+0.98%GBX 15.40GBX 14.8094,684 shs£89.99 million02/13/2024GBX 15.50GBX 15.25-1.61%GBX 15.59GBX 15.2550,937 shs£89.11 million02/12/2024GBX 15.30GBX 15.50+1.31%GBX 15.75GBX 14.69155,951 shs£90.57 million02/09/2024GBX 14.70GBX 15.75+7.14%GBX 15.75GBX 14.7563,753 shs£92.03 million02/08/2024GBX 14.33GBX 14.70+2.62%GBX 15GBX 13.93440,881 shs£85.90 million02/07/2024GBX 14.25GBX 14.33+0.53%GBX 14.40GBX 12.641.53 million shs£83.71 million02/06/2024GBX 15.48GBX 14.25-7.92%GBX 15.38GBX 13.94943,629 shs£83.27 million02/05/2024GBX 15.48GBX 15.48GBX 16.85GBX 15.45668,446 shs£90.36 million02/02/2024GBX 17GBX 15.48-8.97%GBX 17GBX 15.39852,477 shs£90.36 million02/01/2024GBX 18.13GBX 17-6.21%GBX 18.32GBX 15.55775,868 shs£99.27 million01/31/2024GBX 18.03GBX 18.13+0.55%GBX 18.72GBX 17.15437,532 shs£105.84 million01/30/2024GBX 18.05GBX 18.03-0.14%GBX 18.40GBX 17.1679,044 shs£105.25 million01/29/2024GBX 16.25GBX 18.05+11.08%GBX 18.47GBX 16.91263,092 shs£105.40 million01/26/2024GBX 17GBX 16.25-4.41%GBX 16.81GBX 15.83156,118 shs£94.89 million01/25/2024GBX 17GBX 17GBX 17GBX 16.10180,660 shs£99.27 million01/24/2024GBX 17.80GBX 17-4.49%GBX 17.80GBX 16.72263,369 shs£99.25 million01/23/2024GBX 17.25GBX 17.80+3.19%GBX 18GBX 16.6688,591 shs£103.92 millionThe only AI company you should be looking at (Ad)This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.Get the stock ticker here >>>01/22/2024GBX 16.53GBX 17.25+4.39%GBX 17.75GBX 16.251.08 million shs£100.71 million01/19/2024GBX 16.65GBX 16.53-0.75%GBX 17GBX 15.99134,755 shs£96.48 million01/18/2024GBX 16.40GBX 16.65+1.52%GBX 16.88GBX 16.3048,447 shs£97.21 million01/17/2024GBX 15.20GBX 16.40+7.89%GBX 16.40GBX 15.30181,816 shs£95.75 million01/16/2024GBX 13.72GBX 15.20+10.75%GBX 17GBX 15810,162 shs£88.74 million01/15/2024GBX 12.75GBX 13.72+7.64%GBX 14.86GBX 13.70420,947 shs£80.13 million01/12/2024GBX 11.63GBX 12.56+8.04%GBX 12.83GBX 11.05341,498 shs£73.33 million01/11/2024GBX 11.50GBX 11.63+1.09%GBX 12.35GBX 11.51224,985 shs£67.87 million01/10/2024GBX 12GBX 11.50-4.17%GBX 12.24GBX 11.50140,076 shs£67.14 million01/09/2024GBX 12.13GBX 12-1.03%GBX 12.56GBX 12368,931 shs£70.06 million01/08/2024GBX 11.25GBX 12.13+7.78%GBX 12.50GBX 12.12498,997 shs£70.79 million01/05/2024GBX 11.75GBX 11-6.38%GBX 13.60GBX 11690,503 shs£64.22 million01/04/2024GBX 8.96GBX 11.75+31.14%GBX 12.33GBX 9.311.21 million shs£68.60 million01/03/2024GBX 8.41GBX 8.96+6.54%GBX 9.74GBX 8.0296,300 shs£52.31 million01/02/2024GBX 8.24GBX 8.41+2.06%GBX 8.98GBX 8.0443,133 shs£49.10 million01/01/2024GBX 8.24GBX 8.24GBX 8.48GBX 8.0472,878 shs£48.11 million12/29/2023GBX 8GBX 8.24+3.00%GBX 8.48GBX 8.0472,880 shs£48.11 million12/28/2023GBX 8.87GBX 8-9.76%GBX 8.48GBX 852,531 shs£46.71 million12/27/2023GBX 8.13GBX 8.87+9.04%GBX 8.98GBX 8.8740,610 shs£51.76 million12/26/2023GBX 8.13GBX 8.13GBX 8.20GBX 8.0727,376 shs£47.47 million12/25/2023GBX 8.13GBX 8.13GBX 8.20GBX 8.0727,376 shs£47.47 million12/22/2023GBX 8.29GBX 8.13-1.93%GBX 8.20GBX 8.0727,378 shs£47.47 million12/21/2023GBX 8.36GBX 8.29-0.78%GBX 9.11GBX 8.24397,248 shs£48.40 million12/20/2023GBX 8.66GBX 8.36-3.52%GBX 8.50GBX 8.3658,302 shs£48.78 million12/19/2023GBX 8.62GBX 8.66+0.46%GBX 9.25GBX 8.58779,911 shs£50.56 million12/18/2023GBX 8.61GBX 8.62+0.12%GBX 9.48GBX 8.01318,077 shs£50.33 million Related Companies: REDX Stock Price Chart FARN Stock Price Chart SCLP Stock Price Chart TRX Stock Price Chart POLB Stock Price Chart AREC Stock Price Chart C4XD Stock Price Chart DEST Stock Price Chart HEMO Stock Price Chart OBD Stock Price Chart Receive ETX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for e-therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:ETX) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding e-therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.